Evidence mapPaperPMID 40124481Full record

ArticleiScience2025

Pre-cachectic changes in amino acid homeostasis precede activation of eIF2α signaling in the liver at the onset of C26 cancer-induced cachexia.

Ghita Chaouki, Laurent Parry, Cyrielle Vituret, Céline Jousse, Martin Leremboure, Céline Bourgne, Laurent Mosoni, Yoann Delorme, Mehdi Djelloul-Mazouz, Julien Hermet and 8 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ghita ChaoukiUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Laurent ParryUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Cyrielle VituretUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Céline JousseUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Martin LeremboureUniversité Clermont Auvergne, Clermont Auvergne INP, CNRS, Institut de Chimie de Clermont-Ferrand (ICCF), 63000 Clermont-Ferrand, France.
Céline BourgneDigital PCR Platform Facility of the CHU of Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Laurent MosoniUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Yoann DelormeUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Mehdi Djelloul-MazouzUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Julien HermetUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Julien AverousUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Alain BruhatUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Lydie CombaretUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Daniel TaillandierUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Isabelle PapetUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Laure B BindelsMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, UCLouvain, Brussels, Belgium.
Pierre FafournouxUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.
Anne-Catherine MaurinUnité de Nutrition Humaine, INRAE, Université Clermont Auvergne, UMR 1019, F-63000 Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sequence of events associated with cancer cachexia induction needs to be further characterized. Using the C26 mouse model, we found that prior to cachexia, cancer progression was associated with increased levels of IL-6 and growth differentiation factor 15 (GDF15), highly induced production of positive acute phase proteins (APPs) and reduced levels of most amino acids in the systemic circulation, while signal transducer and activator of transcription 3 (STAT3) signaling was induced (1) in the growing spleen, alongside activation of ribosomal protein S6 (rpS6) and alpha subunit of eukaryotic translation initiation factor-2 (eIF2α) signalings, and (2) in the liver, alongside increased positive-APP expression, decreased

Indexed as

CancerCell biologyMolecular biology

Identifiers

PMID40124481
PMCPMC11928868

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.